©The Author(s) 2022.
World J Gastroenterol. Jul 7, 2022; 28(25): 2823-2842
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2823
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2823
Table 2 Long noncoding RNAs downregulated in hepatitis B virus-related hepatocellular carcinoma
| LncRNA name | Regulatory mechanism | Biological function |
| Dreh[84] | Inhibits the vimentin expression and alters its structure | Inhibits proliferation of HCC cells in vitro and tumor growth in vivo |
| LET[85] | LET/NF90/HIF1-α axis | Inhibits HCC invasion |
| uc.306[87] | May participate in the Wnt pathway | Not known |
| UPAT[88] | Promotes ZEB1 degradation | Suppresses cellular migration, invasion, and EMT processes |
| SEMA6A-AS1[89] | Not known | Not known |
| BANCR[90] | Not known | Not known |
| miR143HG[91] | Suppresses the MAPK and Wnt signaling pathways | Inhibits tumor multiplication and metastasis |
| LncRNA-6195[92] | Represses the enzymatic activity of ENO1 | Represses the growth of HCC |
| LINC01352[93] | LINC01352/miR-135b/APC axis | Facilitates HCC progression |
| F11-AS1[94] | lncRNA F11-AS1/miR-211-5p/NR1l3 axis | Inhibits HCC growth and metastasis |
- Citation: Li HC, Yang CH, Lo SY. Long noncoding RNAs in hepatitis B virus replication and oncogenesis. World J Gastroenterol 2022; 28(25): 2823-2842
- URL: https://www.wjgnet.com/1007-9327/full/v28/i25/2823.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i25.2823